I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Iveson, Timothy J
58
results:
Search for persons
X
Format
Online (58)
Mediatypes
Articles (Online) (15)
OpenAccess-fulltext (43)
Sorted by: Relevance
Sorted by: Year
?
1
Codon-specific KRAS mutations predict survival benefit of t..:
van de Haar, Joris
;
Ma, Xuhui
;
Ooft, Salo N.
...
Nature Medicine. 29 (2023) 3 - p. 605-614 , 2023
Link:
https://doi.org/10.1038/..
?
2
SCOT: Tumor Sidedness and the Influence of Adjuvant Chemoth..:
Saunders, Mark P.
;
Iype, Rohan
;
Kelly, Caroline
...
Clinical Colorectal Cancer. 22 (2023) 2 - p. 231-237 , 2023
Link:
https://doi.org/10.1016/..
?
3
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A U..:
Stavraka, Chara
;
Pouptsis, Athanasios
;
Synowiec, Alicja
...
Clinical Colorectal Cancer. 20 (2021) 4 - p. 342-349 , 2021
Link:
https://doi.org/10.1016/..
?
4
Do clinical trials change practice? A longitudinal, interna..:
Hanna, Catherine R.
;
Boyd, Kathleen A.
;
Wincenciak, Joanna
...
Cancer Treatment and Research Communications. 28 (2021) - p. 100445 , 2021
Link:
https://doi.org/10.1016/..
?
5
The Early Impact of the IDEA Collaboration Results: How the..:
Iveson, Timothy
;
Hanna, Catherine
;
Iveson, Poppy
...
JNCI Cancer Spectrum. 5 (2021) 4 - p. , 2021
Link:
https://doi.org/10.1093/..
?
6
Systemic chemotherapy with or without cetuximab in patients..:
Bridgewater, John A
;
Pugh, Siân A
;
Maishman, Tom
...
The Lancet Oncology. 21 (2020) 3 - p. 398-411 , 2020
Link:
https://doi.org/10.1016/..
?
7
Guidelines for time-to-event end-point definitions in adjuv..:
Cohen, Romain
;
Vernerey, Dewi
;
Bellera, Carine
...
European Journal of Cancer. 130 (2020) - p. 63-71 , 2020
Link:
https://doi.org/10.1016/..
?
8
Review of metastatic colorectal cancer treatment pathways a..:
Iveson, Timothy
;
Carter, Angela M.
;
Shiu, Kai-Keen
...
BMC Cancer. 20 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1186/..
?
9
A new prognostic and predictive tool for shared decision ma..:
Sobrero, Alberto F.
;
Puccini, Alberto
;
Shi, Qian
...
European Journal of Cancer. 138 (2020) - p. 182-188 , 2020
Link:
https://doi.org/10.1016/..
?
10
Pattern Recognition Receptor Polymorphisms as Predictors of..:
Gray, Victoria
;
Briggs, Sarah
;
Palles, Claire
...
JNCI: Journal of the National Cancer Institute. 111 (2019) 8 - p. 828-836 , 2019
Link:
https://doi.org/10.1093/..
?
11
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine ..:
Iveson, Timothy J
;
Kerr, Rachel S
;
Saunders, Mark P
...
The Lancet Oncology. 19 (2018) 4 - p. 562-578 , 2018
Link:
https://doi.org/10.1016/..
?
12
SCOT: a comparison of cost-effectiveness from a large rando..:
Robles-Zurita, José
;
Boyd, Kathleen A.
;
Briggs, Andrew H.
...
British Journal of Cancer. 119 (2018) 11 - p. 1332-1338 , 2018
Link:
https://doi.org/10.1038/..
?
13
The IDEA (International Duration Evaluation of Adjuvant Che..:
for the IDEA Steering Committee
;
André, Thierry
;
Iveson, Timothy
...
Current Colorectal Cancer Reports. 9 (2013) 3 - p. 261-269 , 2013
Link:
https://doi.org/10.1007/..
?
14
Response to third-line endocrine treatment for advanced bre..:
Iveson, Timothy J.
;
Ahern, Julie
;
Smith, Ian E.
European Journal of Cancer. 29 (1993) 4 - p. 572-574 , 1993
Link:
https://doi.org/10.1016/..
?
15
Codon-specific KRAS mutations predict survival benefit of t..:
van de Haar, Joris
;
Ma, Xuhui
;
Ooft, Salo N
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033412/. , 2023
Link:
http://www.ncbi.nlm.nih...
1-15